Molecular biology of gastric cancer - PubMed (original) (raw)
Review
. 1995 Jul-Aug;19(4):484-8; discussion 489-90.
doi: 10.1007/BF00294705.
Affiliations
- PMID: 7676688
- DOI: 10.1007/BF00294705
Review
Molecular biology of gastric cancer
E Tahara. World J Surg. 1995 Jul-Aug.
Abstract
Gastric cancer involves changes in multiple oncogenes and multiple suppressor genes, and it causes genetic instability. Aberrant expression and amplification of the c-met gene, inactivation of the p53 gene, and CD44 abnormal transcripts are common events of both well differentiated and poorly differentiated gastric cancers. Amplification of the cyclin E gene is also observed in gastric cancer regardless of histologic type. Decreased expression of the pic1 (p21) gene occurs independent of the p53 mutations. In addition, K-ras mutations, c-erbB-2 gene amplification, loss of heterozygosity (LOH) and mutations of the APC gene, LOH of the bcl-2 gene, and LOH at the DCC locus are preferentially associated with well differentiated gastric cancer. Moreover, LOH on chromosome 1q is involved in the progression of well differentiated cancer. Precancerous lesions, including hyperplastic polyp, intestinal metaplasia, and adenoma, share genetic changes found in well differentiated cancers. Conversely, genetic instability may be involved in the first step of stomach carcinogenesis of the poorly differentiated type. Reduction or loss of cadherin and catenins, K-sam gene amplification, and c-met gene amplification are necessary for the development and progression of poorly differentiated or scirrhous carcinoma. Interaction between cell-adhesion molecules in the c-met expressed tumor cells and hepatocyte growth factor from stromal cells is implicated in the morphogenesis of two types of gastric cancer.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Genetic pathways of two types of gastric cancer.
Tahara E. Tahara E. IARC Sci Publ. 2004;(157):327-49. IARC Sci Publ. 2004. PMID: 15055305 Review. - [Multistep stomach carcinogenesis].
Yokozaki H, Tahara E. Yokozaki H, et al. Nihon Rinsho. 1996 Apr;54(4):1066-71. Nihon Rinsho. 1996. PMID: 8920675 Review. Japanese. - Molecular mechanism of stomach carcinogenesis.
Tahara E. Tahara E. J Cancer Res Clin Oncol. 1993;119(5):265-72. doi: 10.1007/BF01212724. J Cancer Res Clin Oncol. 1993. PMID: 8440743 - Genetic and epigenetic changes in stomach cancer.
Yokozaki H, Yasui W, Tahara E. Yokozaki H, et al. Int Rev Cytol. 2001;204:49-95. doi: 10.1016/s0074-7696(01)04003-7. Int Rev Cytol. 2001. PMID: 11243597 Review. - [Genetic alterations in stomach cancer].
Tahara E, Yasui W, Yokozaki H. Tahara E, et al. Nihon Geka Gakkai Zasshi. 1996 Apr;97(4):252-6. Nihon Geka Gakkai Zasshi. 1996. PMID: 8692139 Review. Japanese.
Cited by
- Gastric cancer: pathogenesis, risks, and prevention.
Sipponen P. Sipponen P. J Gastroenterol. 2002;37 Suppl 13:39-44. doi: 10.1007/BF02990098. J Gastroenterol. 2002. PMID: 12109664 Review. - Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY, Huang TJ, Chen FM, Hsieh MC, Lin SR, Hou MF, Hsieh JS. Wang JY, et al. Virchows Arch. 2003 May;442(5):437-43. doi: 10.1007/s00428-003-0803-5. Epub 2003 Apr 15. Virchows Arch. 2003. PMID: 12695913 - Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
Gylling A, Abdel-Rahman WM, Juhola M, Nuorva K, Hautala E, Järvinen HJ, Mecklin JP, Aarnio M, Peltomäki P. Gylling A, et al. Gut. 2007 Jul;56(7):926-33. doi: 10.1136/gut.2006.114876. Epub 2007 Jan 31. Gut. 2007. PMID: 17267619 Free PMC article. - Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation.
Ishige T, Nishimura M, Satoh M, Fujimoto M, Fukuyo M, Semba T, Kado S, Tsuchida S, Sawai S, Matsushita K, Togawa A, Matsubara H, Kaneda A, Nomura F. Ishige T, et al. Sci Rep. 2016 Feb 19;6:21681. doi: 10.1038/srep21681. Sci Rep. 2016. PMID: 26892343 Free PMC article. - Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer.
Kominea A, Konstantinopoulos PA, Kapranos N, Vandoros G, Gkermpesi M, Andricopoulos P, Artelaris S, Savva S, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG. Kominea A, et al. J Cancer Res Clin Oncol. 2004 May;130(5):253-8. doi: 10.1007/s00432-003-0531-x. Epub 2004 Feb 13. J Cancer Res Clin Oncol. 2004. PMID: 14963700
References
- J Cancer Res Clin Oncol. 1993;119(5):265-72 - PubMed
- Cancer Res. 1993 Nov 1;53(21):5087-9 - PubMed
- Cancer Res. 1994 Jul 1;54(13):3396-7 - PubMed
- Cancer Res. 1992 Jan 15;52(2):295-300 - PubMed
- Biochem Biophys Res Commun. 1992 Nov 30;189(1):227-32 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous